title: Binary blend of glyceryl monooleate and glyceryl monostearate for magnetically induced thermo-responsive local drug delivery system.
abstract: OBJECTIVE
  To develop a novel monoglycerides-based thermal-sensitive drug delivery system, specifically for local intracavitary chemotherapy.
  
  
  METHODS
  Lipid matrices containing mixtures of glyceryl monooleate (GMO) and glyceryl monostearate (GMS) were evaluated for their potential application as magnetically induced thermo-responsive local drug delivery systems using a poorly water-soluble model drug, nifedipine (NF). Oleic acid-modified iron oxide (OA-Fe3O4) nanoparticles were embedded into the GMO-GMS matrix for remote activation of the drug release using an alternating magnetic field (AMF).
  
  
  RESULTS
  The crystallization behavior of binary blends of GMO and GMS as characterized by DSC did show temperature dependent phase transition. GMO-GMS (75:25 wt%) blend showed a melting (T m ) and crystallization (T c ) points at 42°C and 37°C, respectively indicating the potential of the matrix to act as an 'on-demand' drug release. The matrix released only 35% of the loaded drug slowly in 10 days at 37°C whereas 96% release was obtained at 42°C. A concentration of 0.5% OA-Fe3O4 heated the matrix to 42.3 and 45.5°C within 5 min and 10 min of AMF exposure, respectively.
  
  
  CONCLUSIONS
  The in vitro NF release profiles form the monoglycerides matrix containing 0.5% OA-Fe3O4 nanoparticles after AMF activation confirmed the thermo-responsive nature of the matrix that could provide pulsatile drug release 'on-demand'.
authors.affiliation: College of Pharmacy & Health Sciences, Drake University, Des Moines, Iowa, 50311, USA.
authors.forename: Abebe E
authors.initials: AE
authors.lastname: Mengesha
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Wydra
authors.forename: J Zach
authors.initials: JZ
authors.lastname: Hilt
authors.forename: Paul M
authors.initials: PM
authors.lastname: Bummer
mesh_terms: D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D003460:Crystallization; D003692:Delayed-Action Preparations / Q000737:chemistry*; D005989:Glycerides / Q000737:chemistry*; D060526:Magnetic Fields; D058185:Magnetite Nanoparticles / Q000737:chemistry*; D009543:Nifedipine / Q000008:administration & dosage*; D044367:Phase Transition; D013696:Temperature
chemical_list: D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D005989:Glycerides; D058185:Magnetite Nanoparticles; C048159:glyceryl monostearate; C005953:monoolein; D009543:Nifedipine